Stock Price
2.17
Daily Change
-0.18 -7.66%
Monthly
-3.98%
Yearly
69.53%
Q2 Forecast
2.13

Galectin Therapeutics reported $3.7M in Trade Creditors for its fiscal quarter ending in June of 2024.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Galectin Therapeutics USD 3.7M 99K Jun/2024
Gilead Sciences USD 645M 70M Mar/2026
Immunic USD 11.01M 873K Mar/2026
Incyte USD 228.62M 1.41B Mar/2026
Merck USD 3.86B 541M Mar/2026